View in EDS

Immunogenicity and Safety of Homologous Booster Doses of CoronaVac COVID-19 Vaccine in Elderly Individuals Aged 60 Years and Older: A Dosing Interval Study - Yunnan Province, China, 2021-2022.

Saved in:
Bibliographic Details
Title: Immunogenicity and Safety of Homologous Booster Doses of CoronaVac COVID-19 Vaccine in Elderly Individuals Aged 60 Years and Older: A Dosing Interval Study - Yunnan Province, China, 2021-2022.
Authors: Yang H; Yunnan Provincial Center for Disease Control and Prevention, Kunming City, Yunnan Province, China., Meng X; Sinovac Biotech Co., Ltd., Beijing Municipality, China., Zhuang T; School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai Municipality, China., Wang C; Yunnan Provincial Center for Disease Control and Prevention, Kunming City, Yunnan Province, China., Yang Z; Yongde County Center for Disease Control and Prevention, Lincang City, Yunnan Province, China., Zhu T; Sinovac Biotech Co., Ltd., Beijing Municipality, China., Li M; Yongde County Center for Disease Control and Prevention, Lincang City, Yunnan Province, China., Zheng Y; Yunnan Provincial Center for Disease Control and Prevention, Kunming City, Yunnan Province, China., Wu Q; School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai Municipality, China., Hu Y; Sinovac Life Sciences, Beijing Municipality, China., Yu H; School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai Municipality, China., Liu X; Yunnan Provincial Center for Disease Control and Prevention, Kunming City, Yunnan Province, China., Zeng G; Sinovac Biotech Co., Ltd., Beijing Municipality, China.
Source: China CDC weekly [China CDC Wkly] 2023 Feb 10; Vol. 5 (6), pp. 125-130.
Publication Type: Journal Article
Journal Info: Publisher: Chinese Center for Disease Control and Prevention (China CDC) Country of Publication: China NLM ID: 101767554 Publication Model: Print Cited Medium: Internet ISSN: 2096-7071 (Electronic) Linking ISSN: 20967071 NLM ISO Abbreviation: China CDC Wkly Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37008828
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Immunogenicity and Safety of Homologous Booster Doses of CoronaVac COVID-19 Vaccine in Elderly Individuals Aged 60 Years and Older: A Dosing Interval Study - Yunnan Province, China, 2021-2022.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Yang+H%22">Yang H</searchLink>; Yunnan Provincial Center for Disease Control and Prevention, Kunming City, Yunnan Province, China.<br /><searchLink fieldCode="AU" term="%22Meng+X%22">Meng X</searchLink>; Sinovac Biotech Co., Ltd., Beijing Municipality, China.<br /><searchLink fieldCode="AU" term="%22Zhuang+T%22">Zhuang T</searchLink>; School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai Municipality, China.<br /><searchLink fieldCode="AU" term="%22Wang+C%22">Wang C</searchLink>; Yunnan Provincial Center for Disease Control and Prevention, Kunming City, Yunnan Province, China.<br /><searchLink fieldCode="AU" term="%22Yang+Z%22">Yang Z</searchLink>; Yongde County Center for Disease Control and Prevention, Lincang City, Yunnan Province, China.<br /><searchLink fieldCode="AU" term="%22Zhu+T%22">Zhu T</searchLink>; Sinovac Biotech Co., Ltd., Beijing Municipality, China.<br /><searchLink fieldCode="AU" term="%22Li+M%22">Li M</searchLink>; Yongde County Center for Disease Control and Prevention, Lincang City, Yunnan Province, China.<br /><searchLink fieldCode="AU" term="%22Zheng+Y%22">Zheng Y</searchLink>; Yunnan Provincial Center for Disease Control and Prevention, Kunming City, Yunnan Province, China.<br /><searchLink fieldCode="AU" term="%22Wu+Q%22">Wu Q</searchLink>; School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai Municipality, China.<br /><searchLink fieldCode="AU" term="%22Hu+Y%22">Hu Y</searchLink>; Sinovac Life Sciences, Beijing Municipality, China.<br /><searchLink fieldCode="AU" term="%22Yu+H%22">Yu H</searchLink>; School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai Municipality, China.<br /><searchLink fieldCode="AU" term="%22Liu+X%22">Liu X</searchLink>; Yunnan Provincial Center for Disease Control and Prevention, Kunming City, Yunnan Province, China.<br /><searchLink fieldCode="AU" term="%22Zeng+G%22">Zeng G</searchLink>; Sinovac Biotech Co., Ltd., Beijing Municipality, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101767554%22">China CDC weekly</searchLink> [China CDC Wkly] 2023 Feb 10; Vol. 5 (6), pp. 125-130.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Chinese+Center+for+Disease+Control+and+Prevention+%28China+CDC%29%22">Chinese Center for Disease Control and Prevention (China CDC) </searchLink><i>Country of Publication: </i>China <i>NLM ID: </i>101767554 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2096-7071 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220967071%22">20967071 </searchLink><i>NLM ISO Abbreviation: </i>China CDC Wkly <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37008828
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.46234/ccdcw2023.023
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 125
    Titles:
      – TitleFull: Immunogenicity and Safety of Homologous Booster Doses of CoronaVac COVID-19 Vaccine in Elderly Individuals Aged 60 Years and Older: A Dosing Interval Study - Yunnan Province, China, 2021-2022.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Yang H
      – PersonEntity:
          Name:
            NameFull: Meng X
      – PersonEntity:
          Name:
            NameFull: Zhuang T
      – PersonEntity:
          Name:
            NameFull: Wang C
      – PersonEntity:
          Name:
            NameFull: Yang Z
      – PersonEntity:
          Name:
            NameFull: Zhu T
      – PersonEntity:
          Name:
            NameFull: Li M
      – PersonEntity:
          Name:
            NameFull: Zheng Y
      – PersonEntity:
          Name:
            NameFull: Wu Q
      – PersonEntity:
          Name:
            NameFull: Hu Y
      – PersonEntity:
          Name:
            NameFull: Yu H
      – PersonEntity:
          Name:
            NameFull: Liu X
      – PersonEntity:
          Name:
            NameFull: Zeng G
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 10
              M: 02
              Text: 2023 Feb 10
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 2096-7071
          Numbering:
            – Type: volume
              Value: 5
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: China CDC weekly
              Type: main
ResultId 1